ARCHIVES

UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says

This article is from The Cancer Letter archive.

Vol. 25 No. 36 | September 24, 1999

Download PDF Visit The Full Archive

Related Articles

DCT Board Committee Drawing Up Plans On How To Spend Biological Response Modifiers Money

August 31, 1979

Biomarker Identified Predicting Graft-Versus-Host Disease Risk

August 30, 2013

Obit: Same Shapiro, Proponent of Mammographic Screening.

January 7, 2000

Senate committee approves $1.1 billion increase for NIH.

October 1, 2004

Phase 1 AIDS Vaccine Trial Will Involve 81 Persons At NIH

August 28, 1987

Frederick RFP Available Oct. 22; Three Four May Challenge L-B

August 27, 1976